Articles On Resapp Health (ASX:RAP)

Title Source Codes Date
ASX IPOs to Watch in September: A Glimpse at Five Upcoming Listings

The ASX is gearing up for a series of new listings this September, potentially marking a resurgence in initial public offerings (IPOs) after a relatively quiet period. Five companies are set to go public, each bringing something unique to t...

Kalkine Media RAP 3 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead RAP 1 year ago
Why is the ResApp share price lifting today?

The ResApp Health Ltd (ASX: RAP) share price is in the green today as investors digest the latest news on Pfizer’s proposed takeover bid. Shares in the ASX healthcare company are up 0.98%, trading at 21 cents at the time of writing after s...

Motley Fool RAP 2 years ago
ResApp shareholders approve $180m Pfizer takeover

Global biopharmaceutical giant Pfizer will progress with its $180 million takeover of Brisbane-based telehealth company ResApp Health (ASX: RAP) after the target’s shareholders voted in favour of the deal yesterday. As detailed by ResApp,...

businessnewsaustralia.com RAP 2 years ago
Leading health apps taking the Aussie wellbeing industry by storm

It’s no secret that Australia is home to some of the fastest-growing health app companies in the world. Our technology unicorns have been empowering individuals to take control of their health journeys with the ease of tailored experience a...

Stockhead RAP 2 years ago
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks Morgans reviews quarterly results

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

Stockhead RAP 2 years ago
Pfizer raises offer for Australian digital health company

Pfizer has significantly raised its offer for Australian digital health company ResApp Health (ASX:RAP) to a price that reflects the recent findings of an independent report.

BiotechDispatch RAP 2 years ago
Closing Bell: Mrs Pelosi goes to Taipei; Pfizer comes back for ResApp

The ASX 200 is down, the XEC surged late, up 1.5%  Tech stocks rise, Cons discretionary and energy dragging US Futures flat, Chinese markets higher on Pelosi goes to Taipei day   Ahead of the close here in Sydney, US Futures connected to...

Stockhead RAP 2 years ago
ResApp share price explodes 50% on new Pfizer deal

The ResApp Health Ltd (ASX: RAP) share price is leaping on news Pfizer has upped its bid for the company. The biopharmaceutical giant has agreed to acquire the Brisbane-based health technology company for 20.8 cents per share. That’s up...

Motley Fool RAP 2 years ago
ResApp Health (ASX:RAP) uses June quarter to progress research activities

Mobile healthcare company ResApp Health (RAP) used the June quarter to enter new customer agreements and research activities In April, ResApp signed a one-year agreement with the Dartford and Gravesham National Health Service Trust to use...

themarketherald.com.au RAP 2 years ago
ACCC clears Pfizer acquisition of Australian digital health company

Australian digital health company ResApp Health (ASX:RAP) is urging shareholders to support Pfizer's acquisition of the company after the competition regulator confirmed it will not review the proposal.

BiotechDispatch RAP 2 years ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead RAP 2 years ago
Closing Bell: Small caps jump 1.5% as exciting ideas about energy loom large across the ASX

Benchmark up circa 1%, small caps surge 1.5% Coal miners eclipsed by Whitehaven record profits Kincora Copper finds so much more copper The small cap S&P/ASX Emerging Companies (XEC) index and the benchmark S&P/ASX 200 (XJO) index...

Stockhead RAP 2 years ago
CRITERION: It’s a small cap smorgasboard with takeover targets on the table

The takeover action evident at the top end of town is trickling down to the small and mid cap sectors, as mainly foreign marauders avail of the undervalued morsels on offer. In theory, the end of cheap money should have crimped takeover act...

Stockhead RAP 2 years ago
ScoPo’s Powerplays: Much needed July rally for beaten-down ASX health stocks

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. ASX health stocks get much needed July rally aft...

Stockhead RAP 2 years ago
ASX Health Stocks: FDA to expedite submission for Botanix’s sweaty armpits gel

Botanix’s FDA submission gets accelerated Release extends contract with Medgate to use the ResAppDx platform Cyclopharm’s Technegas is used ahead of competitor products in Covid-19 diagnosis Clinical dermatology company, Botanix Pharma (A...

Stockhead RAP 2 years ago
ResApp (ASX:RAP) extends Medgate licence agreement in line with expansion plans

ResApp Health (RAP) agrees to a 12-month extension to its initial one-year commercial licence agreement with Medgate The agreement is to use ResApp’s smartphone-based acute respiratory diagnostic test ResAppDx on Medgate’s telehealth platf...

themarketherald.com.au RAP 2 years ago
ResApp Health extends agreement with Europe's Medgate

Digital health company ResApp Health (ASX:RAP) has agreed to a 12-month extension to its commercial licence agreement with Medgate.

BiotechDispatch RAP 2 years ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead RAP 2 years ago
Evening Report: 6 July, 2022

ShareCafeEvening Report: 6 July, 2022 by Lauren Evans   Australian shares spent the afternoon in the red as commodity prices plunged on recession fears. The energy sector tumbled 5.8 per cent, with materials down 5 per cent. Real estate was...

ShareCafe RAP 2 years ago
ASX200 sheds 0.52% amid commodity plunge; Energy & Materials fall

Highlights: ASX200 loses 0.52%, as commodity prices have likely pressurised materials and energy stocks. Mining stocks FMG and RIO closed lower, while banking stocks CBA and NAB ended on positive note on ASX today. Information technol...

Kalkine Media RAP 2 years ago
FDA okays ResApp’s (ASX:RAP) SleepCheckRx; how are shares faring?

Highlights ResApp Health receives the US Food and Drug Administration (FDA) clearance for its SleepCheckRx mobile application SleepCheckRx is a sleep test that analyses the risk of moderate to severe obstructive sleep apnoea in adults...

Kalkine Media RAP 2 years ago
ASX Health Stocks: ResApp gets FDA nod, while Japan grants Immutep a patent

ResApp gets clearance from the US FDA Immutep is granted patent in Japan Paradigm Biopharma to commence Phase 3 trial ResApp Health (ASX:RAP) announced that SleepCheckRx has received 510(k) clearance as a prescription-only Software-as-a-M...

Stockhead RAP 2 years ago
Lunch Report: 6 July, 2022

ShareCafeLunch Report: 6 July, 2022 by Melissa Darmawan   The Australian sharemarket has been choppy this morning, trading as low as 0.5 per cent before rebounding to a gain of 0.2 per cent to then fall again. Information technology shares...

ShareCafe RAP 2 years ago
ResApp (ASX:RAP) receives FDA clearance for SleepCheckRx

ResApp (RAP) receives 510(k) clearance from the US Food and Drug Administration (FDA) for its at-home sleep test, SleepCheckRx The test is listed as a prescription-only software-as-a-medical device and gaining FDA clearance will enable the...

themarketherald.com.au RAP 2 years ago
ASX Small Cap June Winners: PayGroup pops 164pc on unicorn interest, resources players end on a high

Literally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeover offer from US unicorn Deel Tempest Minerals signed JV to explore near the Karara Magnetite Iron mine June was a month of global econom...

Stockhead RAP 2 years ago
Here’s ResApp’s CEO on what happens next, and the other ASX targets with live offers

ResApp has received an acquisition deal by Pfizer Stockhead reaches out to ResApp’s CEO A list of current ASX stocks with live takeover offers Australia’s global reputation as a fertile ground for innovative companies continues to attract...

Stockhead RAP 2 years ago
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise

Trajan announces SPP to raise up to $5 million after institutional placement raised $29.7 million ResApp CEO and managing director Tony Keating to present at Gold Coast Investment Showcase today Italian authorities approve key Alterity Th...

Stockhead RAP 2 years ago
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Stockhead RAP 2 years ago
ResApp Health’s takeover bid from Pfizer shaved by $53m after disappointing study results

ResApp Health’s (ASX: RAP) shares sank 30% this week after the company announced less than impressive study results on its COVID-19 cough detection app, which has resulted in $53 million being immediately erased from Pfizer’s proposed takeo...

SmallCaps RAP 2 years ago
ASX 200 breaks 7-day losing streak as RBA downplays recession worries

Highlights ASX 200 gained upward momentum after 7 days of losses as RBA wiped off recession fears. Australian mining giants were relieved as iron ore prices recovered some losses today. Top gainers were energy and financial sectors wh...

Kalkine Media RAP 2 years ago
Evening Report: 21 June, 2022

ShareCafeEvening Report: 21 June, 2022 by Melissa Darmawan   Australian shares snapped a seven-day losing streak led by resource and financial stocks amid the US futures pointing to a rise as Wall Street looks to resume trade after a long w...

ShareCafe RAP 2 years ago
Closing Bell: Small caps resurgent as silver mother-lode takes Ted to Tangoa, lifts LDR by 50pc

Emerging Companies (XEC) index rises on Tuesday, up over 1.2% ASX 200 same, but a wee bit more Lode Resources rises sharply on more than just a sliver of silver   Everything’s higher on Tuesday. Not by a heap, but enough to cancel the co...

Stockhead RAP 2 years ago
Why Bowen Coking Coal, Lake Resources, Premier, and ResApp shares are tumbling lower

In afternoon, the S&P/ASX 200 Index (ASX: XJO) is back on form and on course to record a strong gain. At the time of writing, the benchmark index is up 1.5% to 6,531.6 points. Four ASX shares that have failed to follow the market’s...

Motley Fool RAP 2 years ago
Lunch Report: 21 June, 2022

ShareCafeLunch Report: 21 June, 2022 by Melissa Darmawan   The Australian sharemarket is set to snap a seven-day losing streak as investors were relieved that RBA governor Philip Lowe doesn’t see a local recession coming. At noon, the S&amp...

ShareCafe RAP 2 years ago
Stocks of the Hour: ResApp, Radiopharm Theranostics, Reece Pharmaceuticals

21 Jun 2022 - A snapshot of the stocks on the move, featuring ResApp (ASX:RAP), Radiopharm Theranostics (ASX:RAD), and Reece Pharmaceuticals (ASX:RCE).

FNN RAP 2 years ago
ResApp Health (ASX:RAP) shares fall as Pfizer takeover deal drops $53m

ResApp Health (RAP) has plunged into the red after inadequate test results for its COVID-19 detection app shaved $53 million off of a takeover bid from Pfizer An independent confirmation study for RAP’s smartphone-based COVID-19 identifica...

themarketherald.com.au RAP 2 years ago
ASX Health Stocks: ResApp’s COVID-conscious smartphone tool fails new test, shares crash 30pc

ResApp’s independent study of cough app falls short Recce Pharma completes Cohort 6 dosage in Phase 1 trial Proteomics secures exclusive biomakers license Smartphone-based respiratory diagnostic maker, ResApp Health (ASX:RAP), plunged by...

Stockhead RAP 2 years ago
Why is the ResApp share price crashing 29% today?

The ResApp Health Ltd (ASX: RAP) share price has returned from its trading halt and taken a tumble. In morning trade, the digital health company’s shares are down 29% to 12.5 cents. Why is the ResApp share price crashing? Last week, as w...

Motley Fool RAP 2 years ago
Top 10 at 10: The ASX stocks investors like (and dislike) the most in early trade Tuesday

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead RAP 2 years ago
Closing Bell: Nothing crypto in small caps commodity crunch

Emerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper, shares up 70%   Aussie small caps have copped a commodities shellacking to start the week as materials, metals and energy stocks bear the...

Stockhead RAP 2 years ago
Webinar Recap – RAP, WBE & KNO

ShareCafeWebinar Recap – RAP, WBE & KNO Catch up on the full webinar presentations from Resapp (ASX: RAP), Whitebark Energy (ASX: WBE) and Knosys (ASX: KNO) Webinar Recap – RAP, WBE & KNOCompany News

ShareCafe RAP 2 years ago
ResApp (ASX: RAP) – Webinar Presentation

ShareCafeResApp (ASX: RAP) – Webinar Presentation Tony Keating – CEO & Managing Director – ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. More ResApp...

ShareCafe RAP 2 years ago
What the ETF? Aussie ETF providers share positive vibes amid market correction

Pressure put on global economies since the war in Ukraine started a root cause of inflation Vanguard analysis shows investors who stay the course instead of cashing out during volatility are rewarded Energy stocks an inflation hedge over t...

Stockhead RAP 2 years ago
This ASX share is defying the odds to crack new 52-week highs

The S&P/ASX 200 Health Care Index (ASX: XHJ) is in the red today, but this one ASX share is bucking the trend. The ResApp Health Ltd (ASX: RAP) share price is currently at 17 cents, a 3.03% gain. It comes despite the ASX 200 healthca...

Motley Fool RAP 2 years ago
Why Computershare, Lithium Plus, Lynas, and ResApp shares are pushing higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.4% to 6,660.3 points. Four ASX shares that are not letting that hold them back are lis...

Motley Fool RAP 2 years ago
ResApp share price soars on back of increased Pfizer takeover offer

Global pharmaceutical giant Pfizer has almost doubled its initial offer for digital healthcare business ResApp Health (ASX: RAP) to roughly $180 million, after an independent expert found the original April price significantly undervalued t...

businessnewsaustralia.com RAP 2 years ago
A big RAP: This micro cap biotech jumped 50% on Tuesday while the rest of the market bled out

Sydney. Tuesday 14th. 12.34pm. Just as Bridge Street ran slick and red with the blood of investors, fundies, crypto-ingénues, CEOs and their caps – both small and large from sectors across every corner of the market – something strange and...

Stockhead RAP 2 years ago
Closing Bell: ASX plays catch up crash, wins

Benchmark collapses Small caps down 6% Hamelin brings hope   After a really terrific Queen’s Birthday long weekend, local markets already had a session of losses to catch up on at the open. Needless to say, they have. The benchmark took...

Stockhead RAP 2 years ago
Here’s why the ResApp share price is rocketing 50% today

The ResApp Health Ltd (ASX: RAP) share price is by far one of the best performers on the ASX today. This comes as the company provided an update on its proposed acquisition by Pfizer Inc (NYSE: PFE), with trading resuming immediately after...

Motley Fool RAP 2 years ago